$135,607,236

Department of Health and Human Services·Office of Assistant Secretary for Preparedness and Response

ACTION DATE2026-04-07·SOURCEUSASPENDING·SOURCE IDCONT_AWD_75A50121C00059_7505_-NONE-_-NONE-

Award description

THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF THE FRONTLINEODP(TM) SYSTEM FOR PRODUCING A POINT OF CARE PLASMA PRODUCT FOR TRANSFUSION. THE SCOPE IS DEFINED IN THE SOW BELOW.

Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.

The Buildout's read

What the model surfaced from this award

Confidence: high

In plain English

Develop the FrontlineODP system for producing point-of-care plasma products for emergency transfusion.

Sub-sectors

medical-device-developmentpoint-of-care-diagnosticsblood-products

Why this matters

Advances emergency medical capability to produce blood products at point of care, critical for disaster preparedness and remote medical operations.

Supply-chain signal

Signals investment in decentralized plasma production technology; implies demand for portable bioreactor components and plasma processing equipment suppliers.

U.S.–China competition angle

Strengthens U.S. medical countermeasure independence; reduces reliance on centralized blood supply chains vulnerable to disruption.

Generated by award_classification v2.0.0 via claude-haiku-4-5-20251001 on 2026-05-15. Cost: $0.002257.

Period of performance

Start

2021-08-02

End

2029-11-30

Status

activein 1293 days

Recipient

VELICO MEDICAL, INC.

UEI PYD3XN5ZZPJ1

View full profile →

Sources

USAspending.gov — all awards for this UEI →
SAM.gov entity registration →
Award record ingested from usaspending. Source identifier CONT_AWD_75A50121C00059_7505_-NONE-_-NONE-.

The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.